Suchergebnisse - "Anna Jamroz-Wiśniewska"

PubPharm (12)

1

Analysis of Side Effects Following Vaccination Against COVID-19 Among Individuals With Multiple Sclerosis Treated With DMTs in Poland

in: Frontiers in Neurology | 2022

von Agata Czarnowska | Joanna Tarasiuk | Olga Zajkowska | +52

2

Neuropathic pain and chronic pain as an underestimated interdisciplinary problem

in: International Journal of Occupational Medicine and Environmental Health | 2022

von Anna K. Szewczyk | Anna Jamroz-Wiśniewska | Natalia Haratym | +1

3

Novel Drugs in a Pipeline for Progressive Multiple Sclerosis

in: Journal of Clinical Medicine | 2022

von Klaudia Sapko | Anna Jamroz-Wiśniewska | Konrad Rejdak

4

Possible Neuropathic Pain in Clinical Practice—Review on Selected Diagnostic Tools and Its Further Challenges

in: Diagnostics | 2022

von Anna K. Szewczyk | Anna Jamroz-Wiśniewska | Konrad Rejdak

5

Safety of Vaccines against SARS-CoV-2 among Polish Patients with Multiple Sclerosis Treated with Disease-Modifying Therapies

in: Vaccines | 2022

von Agata Czarnowska | Joanna Tarasiuk | Olga Zajkowska | +49

6

Susac syndrome as a multidisciplinary diagnostic challenge

in: Annals of Agricultural and Environmental Medicine | 2021

von Klaudia Sapko | Anna Jamroz-Wiśniewska | Anna Woźniak | +5

7

A Retrospective Analysis of Pain Etiology in Middle-Aged Patients with Peripheral Neuropathy

in: Medicina | 2021

von Anna K. Szewczyk | Anna Jamroz-Wiśniewska | Konrad Rejdak

8

Modified Rio Score with Platform Therapy Predicts Treatment Success with Fingolimod and Natalizumab in Relapsing-Remitting Multiple Sclerosis Patients

in: Journal of Clinical Medicine | 2021

von Anna Jamroz-Wiśniewska | Radosław Zajdel | Agnieszka Słowik | +17

9

Facial Diplegia—Complication or Manifestation of SARS-CoV-2 Infection? A Case Report and Systemic Literature Review

in: Healthcare | 2021

von Anna K. Szewczyk | Urszula Skrobas | Anna Jamroz-Wiśniewska | +2

10

Cladribine Treatment Improved Homocysteine Metabolism and Increased Total Serum Antioxidant Activity in Secondary Progressive Multiple Sclerosis Patients

in: Oxidative Medicine and Cellular Longevity | 2020

von Anna Jamroz-Wiśniewska | Jerzy Bełtowski | Grażyna Wójcicka | +2